Profile photo Helena Verkooijen

Helena Verkooijen

Full Professor

Strategic program(s):

Biography

Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology. 
Medical-scientific director of the Imaging Cluster (incorporating the departments of Radiology, Radiotherapy, Nuclear Medicine and Clinical Physics) at the Antoni van Leeuwenhoek hospital. Leader (PI) of several international research consortia and academic industrial partnership, based at UMC Utrecht. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, panel member, and member of the supervisory board of the Rotterdam Eye Hospital. 
Sharp analytic mind, strong drive and ability to turn ideas into reality. Connector. Passionate about encouraging and facilitating colleagues, team members, and (PhD) students to bring out the best in themselves and each other.

Research groups

Evaluation of imaging and image-guided Interventions

Research aim

The pace of innovation in (AI driven) imaging/image-guided interventions in oncology is high; the window of opportunity for evaluation narrow. We aim to learn from every patient, in order to facilitate evidence-based implementation of innovation.

Go to group

Recent publications

Risk Factors for the Development of Neurological Deficits in Metastatic Spinal Disease Eline H. Huele, Roxanne Gal, Wietse S.C. Eppinga, Helena M. Verkooijen, John E. O’Toole, Ilya Laufer, Daniel M. Sciubba, Cordula Netzer, Wouter Foppen, Arjun Sahgal, Michael G. Fehlings, Sheng fu L. Lo, Charles G. Fisher, Laurence D. Rhines, Jeremy J. Reynolds, Aron Lazary, Alessandro Gasbarrini, Nicolas Dea, Michael H. Weber, Jorrit Jan Verlaan
Global Spine Journal, 2025, vol. 15, p.93S-103S
Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists J. M. Westerhoff, F. J. Raaijmakers, L. A. Daamen, E. N. de Groot-van Breugel, L. T.C. Meijers, J. R.N. van der Voort van Zyp, J. J.C. Verhoeff, S. Mook, H. M. Verkooijen, M. P.W. Intven
Clinical and translational radiation oncology, 2025, vol. 51
Hyperbaric Oxygen Therapy and Late Local Toxic Effects in Patients With Irradiated Breast Cancer Dieuwke R Mink van der Molen, Marilot C T Batenburg, Wiesje Maarse, Desiree H J G van den Bongard, Annemiek Doeksen, Marjoleine Y de Lange, Carmen C van der Pol, Daniel J Evers, Corine A Lansdorp, Jacco van der Laan, Peter M van de Ven, Femke van der Leij, Helena M Verkooijen
JAMA Oncology, 2024, vol. 10, p.464-474
Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study L. A. Daamen, J. M. Westerhoff, A. M. Couwenberg, P. M. Braam, H. Rütten, M. D. den Hartogh, J. P. Christodouleas, W. A. Hall, H. M. Verkooijen, M. P.W. Intven
Clinical and translational radiation oncology, 2024, vol. 45
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy Renée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, Lorenzo Livi, Barbara Alicja Jereczek-Fossa, Hossein Hemmatazad, Michael Mayinger, Heike Peulen, Luc Verbeke, Sara Ramella, Pablo Castro, Pelagia Tsoutsou, Karin Stellamans, Adnan Shaukat, Miha Orazem, Paul Jeene, Pètra Braam, Helena Verkooijen, Inga Malin Simek, Filippo Alongi, Enrico Clementel, Catherine Fortpied, Abigirl Machingura, Felix Boakye Oppong, Matthias Guckenberger, Piet Ost
Clinical and translational radiation oncology, 2024, vol. 45
Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases Bas J J Bindels, Carole Mercier, Roxanne Gal, Jorrit-Jan Verlaan, Joost J C Verhoeff, Piet Dirix, Piet Ost, Nicolien Kasperts, Yvette M van der Linden, Helena M Verkooijen, Joanne M van der Velden
JAMA network open, 2024, vol. 7, p.1-14

External positions

Lid raad van toezicht - Toezicht - BCN / Alexander Monro Ziekenhuis

Lid raad van toezicht - Toezicht - Oogziekenhuis Rotterdam

Lid Commissie Exploratie - Beoordeling wetenschappelijke aanvragen - KWF Kankerbestrijding

bestuurslid - geen - JM Fentener van Vlissingen Fonds

Spreker - ja - Elekta

Lid Wetenschappelijke Adviesraad Landelijk ReferentieCentrum Bevolkingsonderzoek - inhoudelijk - LRCB